Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
09.04. | Diaceutics appoints new VP of marketing | 1 | Sharecast | ||
09.04. | Diaceutics PLC - Appointment of Amie Mc Neice as VP of Marketing | - | RNS | ||
03.04. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan | - | RNS | ||
02.04. | Diaceutics PLC - Director/PDMR/PCA Shareholding & TR1 | - | RNS | ||
21.03. | Diaceutics upgrades diagnositc commercialisation platform, DXRX | 1 | Alliance News | ||
21.03. | Diaceutics PLC - Significant upgrade to Diaceutics' DXRX platform | - | RNS | ||
19.03. | Diaceutics PLC - Diaceutics forms landmark industry Forum | - | RNS | ||
07.03. | Diaceutics PLC - Director/PDMR Shareholding | - | RNS | ||
01.03. | Diaceutics PLC - PDMR Shareholding / SIP and TVR | - | RNS | ||
27.02. | Diaceutics PLC - Expanded lab network and data capabilities | - | RNS | ||
14.02. | IN BRIEF: Diaceutics announces new marketing partnership with KPMG | 1 | Alliance News | ||
14.02. | Diaceutics PLC - Diaceutics PLC - Strategic alliance with KPMG | - | RNS | ||
05.02. | Diaceutics PLC - Appointment of VP, Scientific & Medical Services | - | RNS | ||
01.02. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVR | - | RNS | ||
30.01. | Diaceutics maintains "momentum" for year ahead on revenue rise in 2023 | 1 | Alliance News | ||
30.01. | Diaceutics PLC - Diaceutics PLC - Trading Update | - | RNS | ||
25.01. | Diaceutics PLC - Exercise of Warrant & Total Voting Rights | - | RNS | ||
19.01. | Diaceutics PLC - Diaceutics PLC - Financial Calendar Update | - | RNS | ||
29.12.23 | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan | - | RNS | ||
30.11.23 | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVR | - | RNS |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
DEXCOM | 128,98 | +0,08 % | DexCom Aktie: Umsatzstarkes Wachstum erwartet | DexCom, ein führender Anbieter von kontinuierlichen Glukoseüberwachungssystemen (CGM), hat in den vergangenen Quartalen starke Leistungen gezeigt, wobei die Expansion des Produktportfolios und die hohe... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 1,446 | +2,70 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen | SEATTLE, April 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced promising safety and efficacy data from the Company's Phase 2 EVANGELINE... ► Artikel lesen | |
ASENSUS SURGICAL | 0,243 | +7,51 % | Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG | RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) ("Asensus" or the "Company"), a medical device company that is digitizing the interface... ► Artikel lesen | |
INVIVO THERAPEUTICS HOLDINGS | 0,302 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
SENSEONICS | 0,386 | -4,40 % | Senseonics Holdings, Inc. Announces Data From the Eversense Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes | Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for... ► Artikel lesen | |
RESHAPE LIFESCIENCES | 0,168 | 0,00 % | ReShape Lifesciences Inc: ReShape Lifesciences Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update | Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023; Reaffirming Commitment to Profitability Conference... ► Artikel lesen | |
INTELLIGENT BIO SOLUTIONS | 3,870 | -100,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results | NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
PAVMED | 1,960 | -100,00 % | PAVmed Inc.: PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results | Lucid's quarterly revenue increased 33 percent sequentially
Launched wholly-owned incubator, PMX, to complete development and commercialization of existing portfolio technologies
Conference call and... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 52,76 | +1,15 % | DAX & Co: Sartorius, Netflix, Siemens Healthineers, LVMH, Aixtron und Rheinmetall im Fokus | Der DAX hat am Mittwoch seine Gewinne bis zum Handelsende wieder vollständig abgegeben. Am Ende ging er mit einem Plus von 0,02 Prozent auf 17.770,02 Zähler über die Ziellinie. Am heutigen Donnerstag... ► Artikel lesen | |
FRESENIUS | 27,320 | -1,23 % | JPMORGAN stuft Fresenius SE auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Fresenius auf "Neutral" mit einem Kursziel von 32,50 Euro belassen. Die am 8. Mai anstehenden Quartalszahlen sollten einen ordentlichen Jahresstart... ► Artikel lesen | |
CARL ZEISS MEDITEC | 100,40 | -2,14 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
MOBILE-HEALTH NETWORK SOLUTIONS | 23,880 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 38,960 | -2,36 % | Fresenius und FMC: Aktien im Aufwind - das beflügelt | Die Aktien von Fresenius und ihrer ehemaligen Tochtergesellschaft Fresenius Medical Care (FMC) zeigen am Montag eine robuste Performance. Die Fresenius-Aktie erreichte zwischenzeitlich den höchsten... ► Artikel lesen | |
GERRESHEIMER | 101,40 | -0,59 % | Gerresheimer wieder dreistellig - Jefferies hebt den Daumen | Zum Wochenauftakt geht es für die Gerresheimer-Aktie um zwei Prozent nach oben. Nach einem leichtem Rücksetzer notieren die Scheine damit wieder über 100 Euro. Grund für den Aufschlag ist ein positiver... ► Artikel lesen | |
PROGYNY | 32,600 | +0,62 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen |